                </a></li></ul></div><p><strong>Figure 1.  <span>Characterization of E4G10.</span></strong></p><a id="article1.body1.sec3.sec1.fig1.caption1.p1" name="article1.body1.sec3.sec1.fig1.caption1.p1"></a><p>A, Flow cytometric analysis showing the binding of E4G10 to H5V cells, a mouse endothelioma cell line, in comparison to binding of the positive control anti-CD31 or isotype control antibody. B, X-SPECT gamma camera images of mice (prone, nose at top) at 24, 48 and 72 hours post-injection with <sup>111</sup>In labeled E4G10. C, Biodistribution of <sup>111</sup>In labeled E4G10 at specified time-points post-injection. Data are mean Â± S.E.M. %ID/g = percentage of injected dose per gram of tissue.</p>
